Corporate information

Company type

Developer of treatment to enhance remyelination in neurodegenerative disorders.

Funding rounds

Profile Country
RM Global Partners Venture capital fund that invests in innovative, early stage biopharma assets, through its partnership with FutuRx.


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials